Le Lézard
Classified in: Health, Business
Subjects: CCA, ACC, FVT

Invitation to Cosmo's 2020 results / 2021 outlook presentation conference call on 26 March 2021


DUBLIN, March 19, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals NV (SIX: COPN) invites investors, financial analysts and business/lifescience journalists for a telephone conference on 26 March 2021 with CEO Alessandro Della Chà and CFO Niall Donnelly to discuss the 2020 results and 2021 outlook of the company.

Date:  Friday, 26 March 2021
Time: 02:00 pm CET

Dial-in numbers:
Switzerland / Europe: +41 (0) 58 310 50 00
United Kingdom: +44 (0) 207 107 06 13
United States: +1 (1) 631 570 56 13

The presentation and press release as well as the Annual Report 2020 will be available for download as of 07:00 am CET on 26 March 2021 on www.cosmopharma.com

About Cosmo Pharmaceuticals

Cosmo is a specialty pharmaceutical company focused on developing and commercialising products to treat selected gastrointestinal disorders and improve endoscopy quality measures through aiding the detection of colonic lesions. Cosmo has also developed medical devices for endoscopy and has recently entered into a partnership with Medtronic for the global distribution of GI Geniustm its artificial intelligence device for use in coloscopies and GI procedures. Cosmo has licensed Aemcolo® to Red Hill Biopharma Ltd. for the US and has licensed Relafalk® to Dr. Falk Gmbh for the EU and other countries. For additional information on Cosmo and its products please visit the Company's website: www.cosmopharma.com

Calendar
2020 Full Year Results and 2021 Outlook - March 26, 2021
Annual General Meeting, Amsterdam - May 28, 2021

 

 

 

 

SOURCE Cosmo Pharmaceuticals N.V.


These press releases may also interest you

at 17:50
Breast Tissue Expander Market size is set to grow by USD 282.4 million from 2024-2028, Increasing prevalence of breast cancer boost the market, Technavio
The global breast tissue expander market size is estimated to grow by USD 282.4 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  6.78%  during the forecast period. Increasing prevalence of breast cancer is...

at 17:50
Sleep Apnea Implants Market size is set to grow by USD 401.75 thousand from 2024-2028, Increasing prevalence of sleep apnea and respiratory disorders boost the market, Technavio
The global sleep apnea implants market size is estimated to grow by USD 401.75 thousand from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 15.2% during the forecast period. Increasing prevalence of sleep apnea and...

at 17:45
Implantable Medical Devices Market size is set to grow by USD 53.5 billion from 2024-2028, Rise in number of people with chronic illnesses to boost the market growth, Technavio
The global implantable medical devices market size is estimated to grow by USD 53.5 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.08% during the forecast period. Rise in number of people with chronic...

at 17:35
Transplant Box Market size is set to grow by USD 2.39 billion from 2024-2028, Increasing prevalence of chronic disorders boost the market, Technavio
The global transplant box market size is estimated to grow by USD 2.39 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  10.87%  during the forecast period. Increasing prevalence of chronic disorders is...

at 17:31
BK Virus Infection Market to Witness Surge in Growth During the Study Period (2020-2034) | DelveInsight
DelveInsight's BK Virus Infection Market Insights report includes a comprehensive understanding of current treatment practices, BK virus infection emerging drugs, market share...

at 17:30
Dermatology Devices Market size is set to grow by USD 154.23 billion from 2024-2028, Increasing prevalence of skin disorders to boost the market growth, Technavio
The global dermatology devices market  size is estimated to grow by USD 154.23 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  9.45%  during the forecast period.  Increasing prevalence of skin...

More news about Health...


News published on and distributed by: